FIELD: medicine; pharmacology; biotechnology.
SUBSTANCE: invention relates to medicine, pharmacology, biotechnology, and specifically to cancer treatment. The antitumor agent is ultrashort single-stranded polydeoxyribonucleotides isolated from HL-60 human acute promyelocytic leukemia cells with a chain length of 40-60 ssDNA nitrogen bases 40-60. The agent has pronounced inhibitory effect on the repair enzyme DNA polymerase β.
EFFECT: invention expands the means for the claimed purpose, helps to alleviate the course of cancer and its treatment.
1 cl, 5 dwg, 2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDIUM WITH ANTI-TUMOUR EFFECT AND METHOD OF ITS OBTAINMENT | 2007 |
|
RU2349317C1 |
| TUMOUR THERAPY AGENT | 2019 |
|
RU2726801C1 |
| WATER-SOLUBLE DERIVATIVE OF TRYPTANE-TRIN, HAVING ANTI-TUMOR, ANTI-INFLAMMATORY AND ANTIMICROBIAL ACTIVITY, AND INCREASING THERAPEUTIC ACTIVITY OF ANTI-TUMOR ANTIBIOTICS | 2019 |
|
RU2694058C1 |
| DERIVATIVE OF THE CLASS OF N-GLYCOSIDES INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOLE-5,7-DIONE - N-{12-(β-D-XYLOPYRANOSYL)-5,7-DIOXO-INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOL-6-YL} PYRIDINE-2-CARBOXAMIDE, WHICH HAS CYTOTOXIC AND ANTITUMOR ACTIVITY | 2017 |
|
RU2667906C1 |
| ANTITUMOUR ANTHRAFURANDIONE AND BASED PHARMACEUTICAL COMPOSITIONS | 2014 |
|
RU2554939C1 |
| ANTITUMOR AGENT | 1998 |
|
RU2128042C1 |
| N-GLYCOSIDES OF INDOLO[2,3-a]PYRROLO[3,4-c]CARBAZOLES HAVING ANTITUMOUR ACTIVITY | 2014 |
|
RU2548045C1 |
| ANTITUMOUR AGENT | 2014 |
|
RU2572691C1 |
| ANTI-TUMOR NAPHTHOINDOLE-3-CARBOXAMIDE DERIVATIVE | 2019 |
|
RU2712191C1 |
| OCTA-4,5-CARBOXYLIC ACID PHTHALOCYANINE COBALT ESTERS, THEIR INCLUSION COMPLEXES WITH BETA-CYCLODEXTRIN PROPYLENE GLYCOL ESTER AND METHOD OF SUPPRESSION OF TUMOR GROWTH | 2000 |
|
RU2172319C1 |
